Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Knowing when to save instead of invest is crucial for financial planning. Learn the key moments to prioritize saving for your needs.
23,546 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
The question 'Is corp. stock seriously undervalued?' isn’t easy to answer for FMC. A mix of debt, patent risk, and a ...
Analysts issued a fresh round of high-conviction calls Wednesday, spotlighting Arm Holdings, BorgWarner, GM, Mondelez...
Citi trims its price target for Super Micro Computer to $25 from $39, citing governance and export-control concerns e...
Oil prices surge on geopolitical tensions, lifting energy stocks. This article examines a single ETF that could benef...
Bitcoin miners start funding AI pivots by borrowing and selling BTC to stay liquid as margins tighten, hash prices fa...
NVIDIA still leads the AI chip race, but investors are spreading bets downstream to adjacent AI opportunities as the ...
Five major loan-channel partnerships in five days are redefining how borrowers learn about and secure loans. The rapi...
Applied Digital faces a turning point as it reports another quarter with a strong revenue beat but a mounting debt lo...
A pro-Iranian hacking group claims it accessed the personal email of FBI Director Kash Patel, releasing old photos an...
A Senate bill seeks to shield consumers from rising electricity costs tied to data centers, but policymakers and rese...
ADP’s April payrolls show the private sector added 109,000 jobs, surpassing forecasts and painting a picture of a res...